$Pasithea Therapeutics Corp.(KTTA)$ Bought the pump hoping for an AH squeeze. It didn't happen. So decided to actually check the company. Financials are not awful. Pre-revenue company with 20.5 million cash and 1.5 million loss last quarter. That's enough cash for a couple of quarters. And a brand new FDA approval, which will boost sales. I am very comfortable averaging down and holding for a couple of months.